Dergi makalesi Açık Erişim
Karakus, Gozde Sir; Tastan, Cihan; Kancagi, Derya Dilek; Yurtsever, Bulut; Tumentemur, Gamze; Demir, Sevda; Turan, Raife Dilek; Abanuz, Selen; Cakirsoy, Didem; Seyis, Utku; Ozer, Samed; Elibol, Omer; Elek, Muhammer; Ertop, Gurcan; Arbale, Serap; Elmas, Merve Acikel; Hermsinlioglu, Canso; Kocagoz, Ayse Sesin; Ng, Ozden Hatirnaz; Akyoney, Sezer; Akyoney, Sezer
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/231896</identifier> <creators> <creator> <creatorName>Karakus, Gozde Sir</creatorName> <givenName>Gozde Sir</givenName> <familyName>Karakus</familyName> <affiliation>Acibadem Labcell Cellular Therapy Lab, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Tastan, Cihan</creatorName> <givenName>Cihan</givenName> <familyName>Tastan</familyName> </creator> <creator> <creatorName>Kancagi, Derya Dilek</creatorName> <givenName>Derya Dilek</givenName> <familyName>Kancagi</familyName> <affiliation>Acibadem Labcell Cellular Therapy Lab, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Yurtsever, Bulut</creatorName> <givenName>Bulut</givenName> <familyName>Yurtsever</familyName> <affiliation>Acibadem Labcell Cellular Therapy Lab, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Tumentemur, Gamze</creatorName> <givenName>Gamze</givenName> <familyName>Tumentemur</familyName> <affiliation>Acibadem Mehmet Ali Aydinlar Univ, Vocat Sch Hlth Serv, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Demir, Sevda</creatorName> <givenName>Sevda</givenName> <familyName>Demir</familyName> <affiliation>Yeditepe Univ, Genet & Bioengn Dept, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Turan, Raife Dilek</creatorName> <givenName>Raife Dilek</givenName> <familyName>Turan</familyName> </creator> <creator> <creatorName>Abanuz, Selen</creatorName> <givenName>Selen</givenName> <familyName>Abanuz</familyName> </creator> <creator> <creatorName>Cakirsoy, Didem</creatorName> <givenName>Didem</givenName> <familyName>Cakirsoy</familyName> </creator> <creator> <creatorName>Seyis, Utku</creatorName> <givenName>Utku</givenName> <familyName>Seyis</familyName> <affiliation>Acibadem Labcell Cellular Therapy Lab, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Ozer, Samed</creatorName> <givenName>Samed</givenName> <familyName>Ozer</familyName> <affiliation>Acibadem Mehmet Ali Aydinlar Univ, Anim Applicat & Res Ctr, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Elibol, Omer</creatorName> <givenName>Omer</givenName> <familyName>Elibol</familyName> <affiliation>Acibadem Altunizade Hosp, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Elek, Muhammer</creatorName> <givenName>Muhammer</givenName> <familyName>Elek</familyName> </creator> <creator> <creatorName>Ertop, Gurcan</creatorName> <givenName>Gurcan</givenName> <familyName>Ertop</familyName> <affiliation>Acibadem Mehmet Ali Aydinlar Univ, Vocat Sch Hlth Serv, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Arbale, Serap</creatorName> <givenName>Serap</givenName> <familyName>Arbale</familyName> <affiliation>Acibadem Mehmet Ali Aydinlar Univ, Histol & Embryol Dept, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Elmas, Merve Acikel</creatorName> <givenName>Merve Acikel</givenName> <familyName>Elmas</familyName> <affiliation>Acibadem Mehmet Ali Aydinlar Univ, Histol & Embryol Dept, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Hermsinlioglu, Canso</creatorName> <givenName>Canso</givenName> <familyName>Hermsinlioglu</familyName> <affiliation>Acibadem Labcell Cellular Therapy Lab, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Kocagoz, Ayse Sesin</creatorName> <givenName>Ayse Sesin</givenName> <familyName>Kocagoz</familyName> <affiliation>Acibadem Altunizade Hosp, Infect Dis Unit, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Ng, Ozden Hatirnaz</creatorName> <givenName>Ozden Hatirnaz</givenName> <familyName>Ng</familyName> <affiliation>Acibadem Mehmet Ali Aydinlar Univ, Med Biol Dept, Istanbul, Turkey</affiliation> </creator> <creator> <creatorName>Akyoney, Sezer</creatorName> <givenName>Sezer</givenName> <familyName>Akyoney</familyName> </creator> <creator> <creatorName>Akyoney, Sezer</creatorName> <givenName>Sezer</givenName> <familyName>Akyoney</familyName> </creator> </creators> <titles> <title>Preclinical Efficacy And Safety Analysis Of Gamma-Irradiated Inactivated Sars-Cov-2 Vaccine Candidates</title> </titles> <publisher>Aperta</publisher> <publicationYear>2021</publicationYear> <dates> <date dateType="Issued">2021-01-01</date> </dates> <resourceType resourceTypeGeneral="Text">Journal article</resourceType> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/231896</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1038/s41598-021-83930-6</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract">COVID-19 outbreak caused by SARS-CoV-2 created an unprecedented health crisis since there is no vaccine for this novel virus. Therefore, SARS-CoV-2 vaccines have become crucial for reducing morbidity and mortality. In this study, in vitro and in vivo safety and efficacy analyzes of lyophilized vaccine candidates inactivated by gamma-irradiation were performed. The candidate vaccines in this study were OZG-3861 version 1(V1), an inactivated SARS-CoV-2 virus vaccine, and SK-01 version 1 (V1), a GM-CSF adjuvant added vaccine. The candidate vaccines were applied intradermally to BALB/c mice to assess toxicity and immunogenicity. Preliminary results in vaccinated mice are reported in this study. Especially, the vaccine models containing GM-CSF caused significant antibody production with neutralization capacity in absence of the antibody-dependent enhancement feature, when considered in terms of T and B cell responses. Another important finding was that the presence of adjuvant was more important in T cell in comparison with B cell response. Vaccinated mice showed T cell response upon restimulation with whole inactivated SARS-CoV-2 or peptide pool. This study shows that the vaccines are effective and leads us to start the challenge test to investigate the gamma-irradiated inactivated vaccine candidates for infective SARS-CoV-2 virus in humanized ACE2+ mice.</description> </descriptions> </resource>
Görüntülenme | 68 |
İndirme | 6 |
Veri hacmi | 2.3 kB |
Tekil görüntülenme | 66 |
Tekil indirme | 6 |